Aortic valve replacement for aortic stenosis during orthotopic cardiac transplant

Marco E Larobina1, Justin A Mariani, Michael A Rowland

  • 1Department of Cardiothoracic Surgery, Alfred Hospital, Melbourne, Australia.

Insights

Aortic valve disease in donor hearts, previously a contraindication for cardiac transplantation, can be successfully managed. Donor hearts requiring aortic valve replacement can be safely used, expanding the donor pool for transplant candidates.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Cardiac Surgery

Background:

  • Donor organ availability is limited for cardiac transplantation.
  • Aortic valve disease in donor hearts has been an absolute contraindication.
  • Concomitant surgeries like coronary bypass and mitral/tricuspid valve repair are accepted to expand the donor pool.

Observation:

  • A case of cardiac transplantation using a donor heart with calcific aortic stenosis on a congenitally bicuspid aortic valve is presented.
  • The donor aortic valve required concomitant aortic valve replacement during the transplantation procedure.

Findings:

  • Successful transplantation was achieved with concomitant aortic valve replacement.
  • Eighteen-month follow-up demonstrated excellent allograft function.
  • The mechanical aortic prosthesis functioned normally, ensuring long-term viability.

Implications:

  • Aortic valve disease in donor organs does not necessarily preclude transplantation.
  • Aortic valve replacement at the time of transplant is a viable solution.
  • This approach can expand the donor pool for marginal allografts, benefiting recipients needing cardiac transplants.